Key facts
- Five EU governments have called for unified drug pricing policies.
- They urged member states to avoid uncoordinated reactions to rising medicine costs.
- The statement emphasized the need for a cohesive approach to drug pricing across the European Union.
Five European Union member states have jointly advocated for a unified approach to drug pricing, aiming to present a more cohesive front against rising medicine costs. The governments stressed the importance of aligning policies rather than implementing disparate, uncoordinated responses to cost pressures across the bloc.
The statement highlighted the need for a common strategy to manage pharmaceutical expenditures, suggesting that a fragmented approach could be less effective in addressing the complex issue of drug pricing within the EU.